Posted in

Industry

Dr. Markham featured at STAT review of data from ESMO Virtual Congress

Europe’s largest cancer research meeting, the ESMO Virtual Congress, recently took place on Sept. 19-21. With the event behind us, STAT’s Adam Feuerstein will moderate a panel with some top cancer experts to review the significant data presented at ESMO, discuss what to expect for the rest of the year…

ASCO Daily News: In Hot Pursuit of RAS Inhibition

Thomas George, MD, Associate Professor of Medicine, Department of Medicine, Hematology/Oncology RAS is a common mutation in malignancies yet historically is difficult to inhibit. AMG 510 is a new KRASG12C inhibitor with activity in non‒small cell…